Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1234.60

-10.90 (-0.88%)

< Home < Back

Dr. Reddy’s Laboratories informs about press release

Date: 11-05-2022

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy’s Laboratories enters into exclusive partnership with HK inno.N Corporation to commercialise novel molecule Tegoprazan in India & select Emerging Markets’.

The above information is a part of company’s filings submitted to BSE.